Revelation Biosciences logo
Revelation Biosciences
REVB | NASDAQ
Chart Builder DCF Calculator
$3.82
-$0.44 (-10.43%)
At close: Nov 16, 2026, 4:00 PM ET
$3.75
-$0.07 (-1.83%)
After-hours: Nov 16, 2026, 7:30 PM ET

Revelation Biosciences Company Profile

Company profile explained

Company Profile

Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting the immune system. The company's therapeutic pipeline includes promising candidates such as GEM-AKI, which is being developed as a potential therapy for both the prevention and management of acute kidney injury, and GEM-CKD, intended for the prevention and treatment of chronic kidney disease. Established in 2019, this San Diego, California-based enterprise was formerly known as Petra Acquisition, Inc., before officially adopting the name Revelation Biosciences, Inc. in January 2022.

Key Executives

Name Position
James Rolke Chairman & Chief Executive Officer
Chester Stanley Zygmont Chief Financial Officer & Corporate Secretary
Carol Odle Senior Director of Clinical Projects
Sandra Vedrick Vice President of Human Resources & Investor Relations

Latest SEC Filings

Date Type Title
Aug 19, 2026 8-K Current Report
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 06, 2026 8-K Current Report
Aug 06, 2026 10-Q Quarterly Report
Jul 13, 2026 8-A12B Filing
View All SEC Filings ➞
Revelation Biosciences
Revelation Biosciences logo
Country United States
IPO Date Nov 17, 2020
Industry Biotechnology
Sector Healthcare
Employees 8
CEO James Rolke

Contact Details

4660 La Jolla Village Drive San Diego, California 92122 United States

Stock Details

Ticker Symbol REVB
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001810560
CUSIP Number 76135L887
ISIN Number US76135L8871
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.